An overview of prevalence, determinants and health outcomes of polypharmacy
A high rate of polypharmacy is, in part, a consequence of the increasing proportion of multimorbidity in the ageing population worldwide. Our understanding of the potential harm of taking multiple medications in an older, multi-morbid population, who are likely to be on a polypharmacy regime, is lim...
Saved in:
Main Authors: | Mina Khezrian (Author), Chris J. McNeil (Author), Alison D. Murray (Author), Phyo K. Myint (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polypharmacy: An Overview
by: Nelisa Paidamwoyo Ganga
Published: (2022) -
Systematic review of immunosuppressant guidelines in the COVID-19 pandemic
by: Fenella Barlow-Pay, et al.
Published: (2021) -
Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study
by: Julien Castioni, et al.
Published: (2017) -
Prevalence of polypharmacy: Comparing the status of Indian states
by: Priya Sharma, et al.
Published: (2019) -
Polypharmacy: definition, impact on outcomes, need for correction
by: S. Yu. Martsevich, et al.
Published: (2023)